Table 2.
Up- and down-regulated gene sets in the normal prostate tissue of 16 men with low-risk prostate cancer who engaged in vigorous physical activity ≥3 h/wk compared to 55 men who engaged in <3 h/wk vigorous activity. Gene sets with a false discovery rate (FDR) <0.20 were considered significant.
Gene set name | Source | p-value | FDR |
---|---|---|---|
Up-regulated | |||
G1 Pathway | BIOCARTA | >0.001 | 0.0 |
Formation of Fibrin Clot Clotting Cascade | REACTOME | >0.001 | 0.0 |
Inactivation of APC via Direct Inhibition of the APcomplex | REACTOME | >0.001 | 0.0 |
Cell Cycle | KEGG | 0.001 | 0.10 |
TOB1 Pathway | BIOCARTA | 0.001 | 0.10 |
G2 M Checkpoints | REACTOME | 0.001 | 0.10 |
Phosphorylation of the APC | REACTOME | 0.001 | 0.10 |
APCDC20 Mediated Degradation of Cyclin B | REACTOME | 0.002 | 0.13 |
Chylomicron Mediated Lipid Transport | REACTOME | 0.002 | 0.13 |
E2F Transcriptional Targets at G1 S | REACTOME | 0.002 | 0.13 |
GA12 Pathway | STKE | 0.002 | 0.13 |
E2F Mediated Regulation of DNA Replication | REACTOME | 0.003 | 0.15 |
Homologous Recombination Repair | REACTOME | 0.003 | 0.15 |
Cysteine And Methionine Metabolism | KEGG | 0.004 | 0.15 |
Activation of ATR In Response to Replication Stress | REACTOME | 0.004 | 0.15 |
Complement and Coagulation Cascades | KEGG | 0.005 | 0.15 |
NKT Pathway | BIOCARTA | 0.005 | 0.15 |
Cell Cycle Mitotic | REACTOME | 0.005 | 0.15 |
Cyclin A1 Associated Events During G2 M Transition | REACTOME | 0.005 | 0.15 |
Double Strand Break Repair | REACTOME | 0.005 | 0.15 |
Fanconi Anemia Pathway | REACTOME | 0.005 | 0.15 |
Lipoprotein Metabolism | REACTOME | 0.005 | 0.15 |
Platelet Activation | REACTOME | 0.005 | 0.15 |
NO2-IL12 Pathway | BIOCARTA | 0.006 | 0.17 |
Formation of Platelet Plug | REACTOME | 0.006 | 0.17 |
Down-regulated | |||
SEMA4D in Semaphorin Signaling | REACTOME | >0.001 | 0.0 |
SEMA4D Induced Cell Migration and Growth Cone Collapse | REACTOME | >0.001 | 0.0 |